Axogen Inc.
Organization details
- Legal name
- Axogen Inc.
- Former names
- Lectec Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3845 — Electromedical & Electrotherapeutic Apparatus
- Jurisdiction of incorporation
- Minnesota
- Headquarters city
- Alachua
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AXGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000805928
- EIN
- 41-1301878
Board of directors
-
Alan M. Levine · DirectorSince 2023
-
Amy McBride Wendell · DirectorSince 2023
-
Gregory Gene Freitag · DirectorSince 2023
-
Guido J. Neels · DirectorSince 2023
-
John Johnson · DirectorSince 2023
-
Joseph A. Tyndall · DirectorSince 2023
-
Karen L. Zaderej · Director · CEOSince 2023
-
Kathy Johnson Weiler · DirectorSince 2023
-
Michael D. Dale · Director · CEO and PresidentSince 2024
-
Paul Thomas · DirectorSince 2023
-
William P. Burke · DirectorSince 2023
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 98
19% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of June 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.5%
-
97.3%
-
97.3%
-
97.4%
-
97.6%
-
97.9%
-
98.0%
-
98.1%
Board connections
7 of this board's directors also sit on 10 other boards. 9 are in the same sector.
-
TELA Bio Inc. Same sectorvia Guido J. Neels and Paul Thomas
-
Baxter International Inc. Same sectorvia Amy McBride Wendell
-
Bioventus Inc. Same sectorvia Guido J. Neels
-
CVRx Inc. Same sectorvia Michael D. Dale
-
Elutia Inc. Same sectorvia Guido J. Neels
- via Karen L. Zaderej
-
PDS Biotechnology Corporation Same sectorvia Gregory Gene Freitag
-
Solventum Corporation Same sectorvia Amy McBride Wendell
-
Verastem Inc. Same sectorvia John Johnson
-
Xeris Biopharma Holdings Inc. Same sectorvia John Johnson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $17,061,520
- 34 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Joseph A. Tyndall Director | Open-market sale | −3,500 | $49.70 | $173,950 |
| Aug 11, 2026 | Amy McBride Wendell Director | Option exercise | +13,353 | $14.85 | $198,292 |
| Aug 11, 2026 | Amy McBride Wendell Director | Open-market sale | −13,353 | $48.42 | $646,552 |
| Aug 10, 2026 | Began Marc A Officer (EVP & General Counsel) | Option exercise | +67,500 | $8.16 | $550,800 |
| Aug 10, 2026 | Began Marc A Officer (EVP & General Counsel) | Open-market sale | −67,500 | $47.35 | $3,196,125 |
| Aug 7, 2026 | Kathy Johnson Weiler Director | Open-market sale | −14,150 | $45.30 | $640,995 |
| Jun 19, 2026 | Alan M. Levine Director | Option exercise | +14,150 | — | — |
| Jun 19, 2026 | Kathy Johnson Weiler Director | Option exercise | +14,150 | — | — |
| Jun 19, 2026 | Amy McBride Wendell Director | Option exercise | +14,150 | — | — |
| Jun 19, 2026 | Paul Thomas Director | Option exercise | +18,867 | — | — |
| Jun 19, 2026 | Joseph A. Tyndall Director | Option exercise | +14,150 | — | — |
| Jun 19, 2026 | John Johnson Director | Option exercise | +14,150 | — | — |
| Jun 19, 2026 | William P. Burke Director | Option exercise | +14,150 | — | — |
| May 8, 2026 | Amy McBride Wendell Director | Option exercise | +1,647 | $14.85 | $24,458 |
| May 8, 2026 | Amy McBride Wendell Director | Open-market sale | −1,647 | $42.60 | $70,162 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Axogen Inc.
Who is the CEO of Axogen Inc.?
Michael D. Dale has been Axogen Inc.'s CEO and President since August 2024.
How many directors are on Axogen Inc.'s board?
Axogen Inc.'s board has 11 directors: Alan M. Levine, Amy McBride Wendell, Gregory Gene Freitag, Guido J. Neels, John Johnson, Joseph A. Tyndall, Karen L. Zaderej, Kathy Johnson Weiler, Michael D. Dale, Paul Thomas and 1 other.
Are Axogen Inc. insiders buying or selling shares?
Over the last 12 months, Axogen Inc. insiders made no open-market purchases and sold $17.1 million of shares in 34 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="axogen-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.